secwatch.observer — SEC 8-K summary
======================================

Issuer:     Relay Therapeutics, Inc. (RLAY)
CIK:        0001812364
Form:       8-K
Filed at:   2024-06-03T23:59:59+00:00
Accession:  0000950170-24-067952
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Relay Therapeutics annual meeting; executive compensation advisory vote passes with 60% support
--------------------------------------------------------------------------------

- Stockholders elected Sanjiv K. Patel (109.9M for) and Linda A. Hill (91.3M for) as class I directors.
- Non-binding advisory vote on executive compensation passed: 66.7M for, 44.7M against (40% opposed).
- Ratification of Ernst & Young as auditor for FY2024 approved with 119.4 million votes for.
- Broker non-votes totaled 8.2M on director election and advisory compensation proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1812364/000095017024067952/0000950170-24-067952-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1812364/000095017024067952/rlay-20240603.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-067952

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer